Clinical and Experimental Hypertension Impact Factor, Quartile, Indexing, Ranking

Clinical and Experimental Hypertension Impact Factor, Indexing, Ranking

Clinical and Experimental Hypertension (CEH) is a scholarly journal dedicated to publishing research in the field of Biochemistry Genetics and Molecular Biology, and Published by Taylor & Francis. The Print-ISSN of Clinical and Experimental Hypertension is 10641963

The Publication fees (APC) is 2990 USD; 2392 GBP; 2875 EUR; 4165 AUD.


Clinical and Experimental Hypertension Aim and Scope

Clinical and Experimental Hypertension is published by Taylor & Francis, based in United Kingdom, publishing since 2023. It covers research in Biochemistry Genetics and Molecular Biology, Medicine.

Topics covered include antihypertensive agents, circulatory control, drug development and application, etiology, neurogenic mechanisms, pathophysiology.

The journal is indexed in Scopus, DOAJ; it uses a anonymous peer review process.

Article processing charge: 2990 USD; 2392 GBP; 2875 EUR; 4165 AUD.

For full aims and scope, see the journal's official page.


Clinical and Experimental Hypertension Metrics and Rankings

In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.

Below are the metrics and rankings for the journal Clinical and Experimental Hypertension


Clinical and Experimental Hypertension Abstracting and Indexing

Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars

Abstracting and Indexing

Clinical and Experimental Hypertension Submission

If you would like to submit a manuscript or visit the journal's website, please click on the link below.

Journal Submission 🔗 Journal Website

Featured

Quick Journal Filter

Impact factor List